,i #aagth ,,congress #b;d ,session ,h4 ,r4 #gcdf ,,in ,,the ,,house ,,of ,,representatives ,march #ca1 #bjbb,ms4 ,salazar 7for herself and ,ms4 ,pingree7 introduced the following bill2 which was referred to the ,committee on ,energy and ,commerce1 and in addition to the ,committee on ,ways and ,means1 for a period to be subsequently determined by the ,speaker1 in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned ,a ,,bill ,to amend title ,,xviii of the ,social ,security ,act to provide for coverage and payment of ,alpha-#a ,antitrypsin ,deficiency ,disorder treatment under part ,b of such title1 and for other purposes4 #a4 ,short title ,this ,act may be cited as the ,john ,w4 ,walsh ,alpha-#a ,home ,infusion ,act of #bjbb4 #b4 ,medicare coverage of ,alpha-#a ,antitrypsin ,disorder treatment 7a7 ,in general ,section #ahfa of the ,social ,security ,act 7#db ,u4,s4,c4 #aciex7 is amended-- 7#a7 in subsection 7s77#b7-- 7,a7 by striking and at the end of subparagraph 7,,gg72 7,b7 by inserting and at the end of subparagraph 7,,hh72 and 7,c7 by inserting at the end the following new subparagraph3 7,,ii7 ,alpha-#a ,antitrypsin ,deficiency ,disorder treatment 7as defined in subsection 7lll772 2 and 7#b7 by adding at the end the following new subsection3 7lll7 ,alpha-#a ,antitrypsin ,deficiency ,disorder treatment 7#a7 ,the term ,alpha-#a ,antitrypsin ,deficiency ,disorder treatment means augmentation therapy 7as defined in paragraph 7#b77;,c77 furnished by qualified home infusion therapy suppliers 7as defined in paragraph 7#b77;,d77 which are furnished in the individual's home 7as defined in paragraph 7#b77;,b77 to an individual-- 7,a7 who is under the care of an applicable provider2 7,b7 who is enrolled under both parts ,a and ,b of this title1 and is not enrolled in an ,,ma plan under part ,c of such title2 and 7,c7 who requires augmentation therapy 7as defined in paragraph 7#b77;,c774 7#b7 ,for purposes of this subsection3 7,a7 ,the term applicable provider means-- 7i7 a physician2 7ii7 a nurse practitioner2 and 7iii7 a physician assistant4 7,b7 ,the term home means a place of residence used as the home of an individual 7as defined for purposes of subsection 7n774 7,c7 ,the term augmentation therapy means an ,alpha-#a ,proteinase ,inhibitor indicated for chronic augmentation and maintenance therapy in adults with clinical evidence of emphysema due to severe hereditary deficiency of ,alpha-#a ,antitrypsin4 7,d7 ,the term qualified home infusion therapy supplier has the meaning given such term in subsection 7iii77#c77;,d77i74 4 7b7 ,payment for intravenous administration kits and nursing services for ,alpha-#a ,antitrypsin ,deficiency ,disorder treatment ,section #ahcd of the ,social ,security ,act 7#db ,u4,s4,c4 #aciem7 is amended by adding at the end the following new subsection3 7z7 ,payment for intravenous administration kits and nursing services for ,alpha-#a ,antitrypsin ,deficiency ,disorder treatment ,the ,secretary shall implement a payment system under which payment is made under this title to a qualified home infusion therapy supplier 7as defined in section #ahfa7lll77#c77;,d77 for intravenous administration kits and nursing services for up to #b hours of care by a qualified home infusion therapy supplier in coordination with the furnishing of augmentation therapy 7as defined in section #ahfa7lll77#b77;,c774 4 7c7 ,conforming amendments 7#a7 ,payment reference ,section #ahcc7;a77#a7 of the ,social ,security ,act 7#db ,u4,s4,c4 #aciel7a77#a77 is amended-- 7,a7 by striking and before 7,,dd72 and 7,b7 by inserting before the semicolon at the end the following3 1 and 7,,ee7 with respect to intravenous administration kits and nursing services described in section #ahcd7z7 for ,alpha-#a ,antitrypsin ,disorder treatment 7as defined in subsection 7lll77#a771 the amount paid for such kits and services shall be an amount equal to #hj percent of the lesser of the actual charge for the services or the amount determined under section #ahcd7z74 7#b7 ,direct payment ,the first sentence of section #ahdb7;b77#f7 of the ,social ,security ,act 7#db ,u4,s4,c4 #acieu7b77#f77 is amended-- 7,a7 by striking and before 7,j72 and 7,b7 by inserting before the period at the end the following3 1 and 7,k7 in the case of intravenous administration kits and nursing services described in section #ahcd7z71 payment shall be made to the qualified home infusion therapy supplier 7as defined in section #ahfa7lll77#b77;,d774 7#c7 ,exclusion from home health services ,section #ahfa7m7 of the ,social ,security ,act 7#db ,u4,s4,c4 #aciex7m77 is amended1 in the first sentence1 by inserting the following before the period at the end3 and intravenous administration kits and nursing services described in section #ahcd7z7 for ,alpha-#a ,antitrypsin ,deficiency ,disorder treatment 7as defined in subsection 7lll77#a774 7d7 ,effective date ,the amendments made by this section shall apply to items and services furnished on or after ,january #a1 #bjbc4